Bank of Montreal’s Mustang Bio MBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-2
Closed -$6K 4415
2021
Q1
$6K Sell
2
-9
-82% -$26.8K ﹤0.01% 4578
2020
Q4
$36K Buy
11
+9
+450% +$21.5K ﹤0.01% 4116
2020
Q3
$5K Sell
2
-1
-33% -$2.46K ﹤0.01% 4432
2020
Q2
$8K Buy
3
+2
+200% +$4.68K ﹤0.01% 4274
2020
Q1
$2K Sell
1
-5
-83% -$12.8K ﹤0.01% 3867
2019
Q4
$18K Buy
6
+2
+50% +$4.58K ﹤0.01% 4366
2019
Q3
$11K Sell
4
-1
-20% -$2.74K ﹤0.01% 4380
2019
Q2
$14K Buy
+5
New +$14.3K ﹤0.01% 4373
2019
Q1
Hold
0
-$1K 4562
2018
Q4
Sell
-1
Closed -$3.04K 4540
2018
Q3
$3K Buy
+1
New +$5K ﹤0.01% 4244
2018
Q2
Hold
0
4552

Other funds holding MBIO

Bank of Montreal's MBIO Position: Q2 2021 in Review

Bank of Montreal sold out of Mustang Bio (MBIO) in Q2 2021, closing a stake of 2 shares — an estimated $6K sold.

Bank of Montreal first reported a position in MBIO in Q3 2018 and held it in 9 quarters. The position peaked at $36K in Q4 2020. 92 funds tracked by Wall St. Rank hold MBIO as of Q2 2021.

  • Bank of Montreal reported no remaining Mustang Bio position as of Q2 2021 after selling out during the quarter.
  • Bank of Montreal sold 2 Mustang Bio shares in Q2 2021, an estimated $6K.
  • Bank of Montreal first reported a position in Mustang Bio in Q3 2018 and held it in 9 quarters.
  • Bank of Montreal's Mustang Bio position peaked at $36K in Q4 2020.
  • 92 funds tracked by Wall St. Rank held Mustang Bio as of Q2 2021.

Based on Bank of Montreal's 13F filing for Q2 2021, filed 12 Aug 2021.